Mesa Laboratories, Inc. announced its financial results for the second fiscal quarter ended September 30, 2026. Total revenues for the quarter increased 2.6% to $62,336 compared to the same prior year period. Operating income increased 77.6% to $8,388, while net income increased
Perspective Therapeutics, Inc. reported its financial results for the third quarter ended September 30, 2026. The company reported cash, cash equivalents, and short-term investments of approximately $202 million as of September 30, 2026, compared to approximately $145 million as
Effective November 5, 2026, the Board of Directors of GeoVax Labs, Inc. appointed Shahin Behroyan as a director of the Company. Mr. Behroyan was appointed directly by the Board of Directors, by the affirmative vote of a majority of the directors then in office. Mr. Behroyan was a
Perspective Therapeutics, Inc. reported its financial results for the third quarter ended September 30, 2026. The company reported cash, cash equivalents, and short-term investments of approximately $202 million as of September 30, 2026, compared to approximately $145 million as
Effective November 5, 2026, the Board of Directors of GeoVax Labs, Inc. appointed Shahin Behroyan as a director of the Company. Mr. Behroyan was appointed directly by the Board of Directors, by the affirmative vote of a majority of the directors then in office. Mr. Behroyan was a
(RTTNews) - Bandai Namco Holdings Inc. (7832.T) reported first half profit to owners of parent of 99.5 billion yen, an increase of 26.1% from prior year. Basic earnings per share was 155.14 yen compared to 121.91 yen. For the six months ended September 30, 2026, net sales were 72
SPCX is rebounding on Musk's ambitious $500 billion revenue forecast, surging earnings estimates and expanding AI infrastructure, while its Qualcomm partnership targets wireless growth.
The average one-year price target for Vontier (NYSE:VNT) (BMV:VNT1) has been revised to $45.57 / share, as of November 6, 2026. This is an increase of 10.65% from the prior estimate of $41.18 dated October 30, 2026. These figures represent aggregate analyst targets compiled by Fi
The average one-year price target for Vontier (NYSE:VNT) (BMV:VNT1) has been revised to $45.57 / share, as of November 6, 2026. This is an increase of 10.65% from the prior estimate of $41.18 dated October 30, 2026. These figures represent aggregate analyst targets compiled by Fi
(RTTNews) - European stocks are seen opening mostly higher on Tuesday after U.S. benchmark indexes saw their biggest rally in over seven months overnight, led by technology firms.
(RTTNews) - European stocks are seen opening mostly higher on Tuesday after U.S. benchmark indexes saw their biggest rally in over seven months overnight, led by technology firms.
Corn futures closed the Monday session with contracts slipping 2 to 3 cents lower into the final bell. The CmdtyView national average Cash Corn price was down 1 1/2 cents at $4.05 3/4. USDA reported a private export sale of 110,000 MT of corn to Mexico this morning, all for...
Corn futures closed the Monday session with contracts slipping 2 to 3 cents lower into the final bell. The CmdtyView national average Cash Corn price was down 1 1/2 cents at $4.05 3/4. USDA reported a private export sale of 110,000 MT of corn to Mexico this morning, all for...
HNGE's rapid revenue growth, expanding client base and AI-powered care offerings contrast with TRIP's AI-driven traffic declines and weakening earnings outlook.
UnitedHealth Group Incorporated announced the appointment of Madeline Bell to serve as an independent director of the Company, effective November 3, 2026. Ms. Bell has not yet been appointed to any committees of the Company's Board of Directors. She will receive compensation for
UnitedHealth Group Incorporated announced the appointment of Madeline Bell to serve as an independent director of the Company, effective November 3, 2026. Ms. Bell has not yet been appointed to any committees of the Company's Board of Directors. She will receive compensation for
Genuine Parts Company announced that its Board of Directors declared a regular quarterly cash dividend of one dollar and six and one quarter cents ($1.0625) per share on the company’s common stock. The dividend is payable on January 5, 2027 to shareholders of record on Dece
Genuine Parts Company announced that its Board of Directors declared a regular quarterly cash dividend of one dollar and six and one quarter cents ($1.0625) per share on the company’s common stock. The dividend is payable on January 5, 2027 to shareholders of record on Dece